Cargando…

Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder

PURPOSE: Cravings for drugs and alcohol have been significantly associated with worse treatment outcomes. We investigated if improvements in recovery capital (RC) (eg, a measure of social capital/network, financial resources, education, and cultural factors) over time were associated with decreased...

Descripción completa

Detalles Bibliográficos
Autores principales: Bormann, Nicholas L, Weber, Andrea N, Miskle, Benjamin, Arndt, Stephan, Lynch, Alison C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561754/
https://www.ncbi.nlm.nih.gov/pubmed/37818109
http://dx.doi.org/10.2147/SAR.S433350
_version_ 1785117989179228160
author Bormann, Nicholas L
Weber, Andrea N
Miskle, Benjamin
Arndt, Stephan
Lynch, Alison C
author_facet Bormann, Nicholas L
Weber, Andrea N
Miskle, Benjamin
Arndt, Stephan
Lynch, Alison C
author_sort Bormann, Nicholas L
collection PubMed
description PURPOSE: Cravings for drugs and alcohol have been significantly associated with worse treatment outcomes. We investigated if improvements in recovery capital (RC) (eg, a measure of social capital/network, financial resources, education, and cultural factors) over time were associated with decreased reported cravings. PATIENTS AND METHODS: The original cohort consisted of 133 participants (63 females) with opioid use disorder seeking outpatient treatment, who completed the Assessment of Recovery Capital (ARC) (range 0 to 50) and the Brief Addiction Monitor (BAM) thrice over the 6-month study. Intervention was medication and case management. Analysis included one-way mixed models testing change over time for ARC total scores and single question craving rating (5-point Likert scale). Cross-lagged panel estimates used structural equation models with variables z-scored, allowing for path coefficient evaluation as standard deviations (sd). RESULTS: Total ARC significantly increased over the study (χ2 = 33.77, df = 2, p < 0.0001), with baseline of 36.6 (n = 114, sd = 11.1) and 6-month of 41.2 (n = 107, sd = 9.5). Craving also changed significantly (χ2 = 8.51, df = 2, p < 0.015), with baseline of 1.1 (n = 101, sd = 1.2) and 6-month of 0.9 (n = 107, sd = 1.1). The cross-lag from baseline RC to 3-month craving was significant (β = −0.28, SE = 0.11, z = −2.53, p < 0.011). The converse was not true; baseline craving did not affect later RC. Results were similarly significant when comparing 3-month to 6-month. The majority of sample was on buprenorphine. CONCLUSION: As RC improves, the reported cravings at both 3- and 6-month study time points are significantly reduced. When evaluated inversely, there was not a significant association with baseline cravings and follow-up RC. Significant path coefficients provide an estimation of a directional effect from increased RC towards craving reduction.
format Online
Article
Text
id pubmed-10561754
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-105617542023-10-10 Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder Bormann, Nicholas L Weber, Andrea N Miskle, Benjamin Arndt, Stephan Lynch, Alison C Subst Abuse Rehabil Original Research PURPOSE: Cravings for drugs and alcohol have been significantly associated with worse treatment outcomes. We investigated if improvements in recovery capital (RC) (eg, a measure of social capital/network, financial resources, education, and cultural factors) over time were associated with decreased reported cravings. PATIENTS AND METHODS: The original cohort consisted of 133 participants (63 females) with opioid use disorder seeking outpatient treatment, who completed the Assessment of Recovery Capital (ARC) (range 0 to 50) and the Brief Addiction Monitor (BAM) thrice over the 6-month study. Intervention was medication and case management. Analysis included one-way mixed models testing change over time for ARC total scores and single question craving rating (5-point Likert scale). Cross-lagged panel estimates used structural equation models with variables z-scored, allowing for path coefficient evaluation as standard deviations (sd). RESULTS: Total ARC significantly increased over the study (χ2 = 33.77, df = 2, p < 0.0001), with baseline of 36.6 (n = 114, sd = 11.1) and 6-month of 41.2 (n = 107, sd = 9.5). Craving also changed significantly (χ2 = 8.51, df = 2, p < 0.015), with baseline of 1.1 (n = 101, sd = 1.2) and 6-month of 0.9 (n = 107, sd = 1.1). The cross-lag from baseline RC to 3-month craving was significant (β = −0.28, SE = 0.11, z = −2.53, p < 0.011). The converse was not true; baseline craving did not affect later RC. Results were similarly significant when comparing 3-month to 6-month. The majority of sample was on buprenorphine. CONCLUSION: As RC improves, the reported cravings at both 3- and 6-month study time points are significantly reduced. When evaluated inversely, there was not a significant association with baseline cravings and follow-up RC. Significant path coefficients provide an estimation of a directional effect from increased RC towards craving reduction. Dove 2023-10-05 /pmc/articles/PMC10561754/ /pubmed/37818109 http://dx.doi.org/10.2147/SAR.S433350 Text en © 2023 Bormann et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Bormann, Nicholas L
Weber, Andrea N
Miskle, Benjamin
Arndt, Stephan
Lynch, Alison C
Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title_full Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title_fullStr Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title_full_unstemmed Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title_short Recovery Capital Gains May Precede Craving Reduction in Opioid Use Disorder
title_sort recovery capital gains may precede craving reduction in opioid use disorder
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10561754/
https://www.ncbi.nlm.nih.gov/pubmed/37818109
http://dx.doi.org/10.2147/SAR.S433350
work_keys_str_mv AT bormannnicholasl recoverycapitalgainsmayprecedecravingreductioninopioidusedisorder
AT weberandrean recoverycapitalgainsmayprecedecravingreductioninopioidusedisorder
AT misklebenjamin recoverycapitalgainsmayprecedecravingreductioninopioidusedisorder
AT arndtstephan recoverycapitalgainsmayprecedecravingreductioninopioidusedisorder
AT lynchalisonc recoverycapitalgainsmayprecedecravingreductioninopioidusedisorder